中华消化外科杂志
中華消化外科雜誌
중화소화외과잡지
CHINESE JOURNAL OF DIGESTIVE SURGERY
2010年
5期
367-369
,共3页
陈鸿强%张帆%叶永强%孟庆义%成雨%陈雨信
陳鴻彊%張帆%葉永彊%孟慶義%成雨%陳雨信
진홍강%장범%협영강%맹경의%성우%진우신
布加综合征%人工血管%转流
佈加綜閤徵%人工血管%轉流
포가종합정%인공혈관%전류
Budd-Chiari syndrome%Artificial vessels%Shunt
目的 探讨应用人工血管行肠-腔-房转流术(MCAS)治疗混合型布加综合征的临床效果.方法 回顾性分析2000年2月至2004年5月山东大学齐鲁医院收治的17例混合型布加综合征患者的临床资料.17例患者均为全部或两支肝静脉主干阻塞且肝后下腔静脉长段血栓形成或长段闭塞(或)狭窄,应用人工血管行MACS.观察并比较患者手术前后的临床症状、门静脉及下腔静脉压力;患者术后并发症发生率;人工血管通畅率.采用Kaplan-Meier法分析患者生存率,χ2检验和t检验分析相关数据.结果 全组患者无围手术期死亡.17例患者中15例临床症状消失或缓解,与术前比较,差异有统计学意义(χ2=9.78,P<0.05);3例出现并发症;门静脉及下腔静脉压力术后较术前平均下降1.2 cm H2O(1 cm H2O=0.098 kPa)和18.5 cm H2O,其差异有统计学意义(t=2.38,3.06,P<0.05);1、3、5年生存率分别为16/17、15/17、14/17;5年人工血管通畅率为14/17.结论 MCAS可同时缓解混合型布加综合征的门静脉高压和下腔静脉高压,术后降压效果明显,并发症少,5年生存率和人工血管通畅率高,是一种可供选择的手术方式.
目的 探討應用人工血管行腸-腔-房轉流術(MCAS)治療混閤型佈加綜閤徵的臨床效果.方法 迴顧性分析2000年2月至2004年5月山東大學齊魯醫院收治的17例混閤型佈加綜閤徵患者的臨床資料.17例患者均為全部或兩支肝靜脈主榦阻塞且肝後下腔靜脈長段血栓形成或長段閉塞(或)狹窄,應用人工血管行MACS.觀察併比較患者手術前後的臨床癥狀、門靜脈及下腔靜脈壓力;患者術後併髮癥髮生率;人工血管通暢率.採用Kaplan-Meier法分析患者生存率,χ2檢驗和t檢驗分析相關數據.結果 全組患者無圍手術期死亡.17例患者中15例臨床癥狀消失或緩解,與術前比較,差異有統計學意義(χ2=9.78,P<0.05);3例齣現併髮癥;門靜脈及下腔靜脈壓力術後較術前平均下降1.2 cm H2O(1 cm H2O=0.098 kPa)和18.5 cm H2O,其差異有統計學意義(t=2.38,3.06,P<0.05);1、3、5年生存率分彆為16/17、15/17、14/17;5年人工血管通暢率為14/17.結論 MCAS可同時緩解混閤型佈加綜閤徵的門靜脈高壓和下腔靜脈高壓,術後降壓效果明顯,併髮癥少,5年生存率和人工血管通暢率高,是一種可供選擇的手術方式.
목적 탐토응용인공혈관행장-강-방전류술(MCAS)치료혼합형포가종합정적림상효과.방법 회고성분석2000년2월지2004년5월산동대학제로의원수치적17례혼합형포가종합정환자적림상자료.17례환자균위전부혹량지간정맥주간조새차간후하강정맥장단혈전형성혹장단폐새(혹)협착,응용인공혈관행MACS.관찰병비교환자수술전후적림상증상、문정맥급하강정맥압력;환자술후병발증발생솔;인공혈관통창솔.채용Kaplan-Meier법분석환자생존솔,χ2검험화t검험분석상관수거.결과 전조환자무위수술기사망.17례환자중15례림상증상소실혹완해,여술전비교,차이유통계학의의(χ2=9.78,P<0.05);3례출현병발증;문정맥급하강정맥압력술후교술전평균하강1.2 cm H2O(1 cm H2O=0.098 kPa)화18.5 cm H2O,기차이유통계학의의(t=2.38,3.06,P<0.05);1、3、5년생존솔분별위16/17、15/17、14/17;5년인공혈관통창솔위14/17.결론 MCAS가동시완해혼합형포가종합정적문정맥고압화하강정맥고압,술후강압효과명현,병발증소,5년생존솔화인공혈관통창솔고,시일충가공선택적수술방식.
Objective To investigate the therapeutic effect of the meso-cavo-atrial shunt (MCAS) in the treatment of combined Budd-Chiari syndrome (BCS). Methods The clinical data of 17 cases of combined BCS with all or bilateral hepatic vein occlusion and long range occlusion or obstruction of inferior vena cava (IVC) were admitted to the Qilu Hospital from February 2000 to May 2004. All patients were treated by MCAS with artificial blood vessels. The pre- and postoperative clinical symptoms, the IVC and portal venous (PV) pressures, the incidence of postoperative complications and the patency rate of the artificial vessels were analyzed. The survival of patients was analyzed using the Kaplan-Meier analysis, and the data were analyzed using the chi-square test and t test. Results No patient died during the perioperative period, and the symptoms of 15 patients disappeared or were relieved after operation, with a significant difference compared with those before operation (χ2 =9.78, P <0. 05 ). Three patients had complications after the operation. The postoperative PV and IVC pressures were decreased by 1.2 cm H2O (1 cm H2O =0.098 kPa) and 18.5 cm H2O, respectively. There were significant differences in the decrease of IVC and PV pressures ( t = 2.38, 3.06, P < 0.05 ). The 1-, 3-, 5-year survival rates were 16/17, 15/17 and 14/17, respectively, and the 5-year patency rate of the artificial vessels was 14/17.Conclusions MCAS can simultaneously relieve IVC and PV hypertension for patients with combined BCS. The postoperative complication rate was decreased, the 5-year survival rate and the patency rate of the artificial vessels were improved after the treatment, so MCAS is an optional surgical method for treating combined BCS.